Epothilone B in Treating Patients With CNS Metastases From Breast Cancer

Completed · Phase 2

Conditions studied: Breast Cancer, Metastatic Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as epothilone B, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well epothilone B works in treating patients with CNS metastases from breast cancer.

Key facts

Study ID

NCT00450866

Run by

David Peereboom, MD

People needed

55

Starts

2007-01-01

Expected to finish

2012-05-01

Last updated by the study team

2014-02-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
• Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.